Tesamorelin has been extensively studied for its ability to stimulate endogenous growth hormone (GH) and insulin-like growth factor-1 (IGF-1) secretion. Preclinical and clinical research models show that Tesamorelin activates the GHRH receptor, leading to increased pulsatile GH release and downstream effects on metabolism, fat utilization, and muscle-supporting pathways.
Body Composition & Lipid Metabolism — Tesamorelin is widely studied for its effects on visceral adipose tissue (VAT). Research demonstrates reductions in abdominal fat, improved lipid oxidation, and beneficial changes in triglyceride metabolism. These effects make Tesamorelin a valuable compound in metabolic and obesity-related research.
IGF-1 Modulation — Tesamorelin increases circulating IGF-1 concentrations through GH stimulation. IGF-1 plays a critical role in muscle protein synthesis, tissue repair, and anabolic signaling, making Tesamorelin relevant for research in musculoskeletal and age-related decline models.
Metabolic Function & Glucose Regulation — Studies suggest Tesamorelin may influence insulin sensitivity and glucose tolerance parameters. While results vary across models, Tesamorelin remains of interest for investigating glucose uptake and glycemic control mechanisms.
Neurocognitive Research — Emerging studies indicate Tesamorelin may help counteract neurodegenerative changes in certain populations by influencing brain lipid metabolism and growth-factor signaling.